Announcements Trials

Browse Landscape

Sponsor

Conditions

Uterine Cervical Neoplasms 5 Ovarian Neoplasms 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Non-Small-Cell Lung 2 Lung Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Gemcitabine 43 pembrolizumab 36 Paclitaxel 36 Nivolumab 31 Docetaxel 29 Capecitabine 29 Bevacizumab 29 Oxaliplatin 28 Fluorouracil 28 Cisplatin 26 Leucovorin 24 Cyclophosphamide 23 Radiosurgery 20 Irinotecan 20 Carboplatin 20 aldesleukin 19 Cetuximab 19 Interleukin-2 16 fludarabine phosphate 15 fludarabine 15 Pemetrexed 15 Trastuzumab 14 Magnetic Resonance Spectroscopy 14 Ipilimumab 14 Fulvestrant 14 130-nm albumin-bound paclitaxel 14 Prednisone 13 Everolimus 13 Radiotherapy 12 Panitumumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × tisotumab vedotin × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡